Immunological strategies to fight skin cancer

B Berman1, O A Perez, D Zell

  • 1Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, USA.

Skin Therapy Letter
|July 6, 2006
PubMed

Insights

Immunomodulators are increasingly vital for treating skin cancers like melanoma. These therapies boost the immune system, offering noninvasive options for patients unsuitable for surgery.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Skin cancer represents a global epidemic and the most common human cancer.
  • There is a growing interest in immunomodulators for treating various skin cancers, including melanoma and nonmelanoma types.

Purpose of the Study:

  • To explore the role of immunomodulators in treating diverse skin cancers.
  • To review strategies for augmenting the host immune response against cancer cells.

Main Methods:

  • Investigated strategies include recombinant cytokines, immunomodulators, dendritic cell immunization, tumor antigen vaccination, T-cell-based immunotherapy, and gene therapy.
  • Reviewed current standard treatments such as Mohs surgery, curettage, and radiotherapy.

Main Results:

  • Immunomodulators are emerging as essential treatments for specific skin cancers.
  • These therapies offer noninvasive alternatives for patients who are poor surgical candidates.

Conclusions:

  • Immunomodulators represent a significant advancement in skin cancer treatment.
  • They provide crucial therapeutic options, particularly for patients requiring noninvasive approaches.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview